ArticleVascular health and risk management2025
Remnant Cholesterol is Associated with Blood Pressure Control in US Adults with Hypertension: NHANES 2007-2018 Analysis.
Article in Vascular health and risk management, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prognostic value of combined LDL-C and remnant cholesterol stratification for 24-month major adverse cardiovascular events after primary PCI in patients with STEMI.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: High blood pressure is a major risk factor for cardiovascular and renal diseases, and lipid metabolism disorders may affect blood pressure through mechanisms such as endothelial inflammation. Remnant cholesterol, a key component of triglyceride-rich lipoproteins, has been recognized as a causal factor for atherosclerosis and metabolic disorders. This study aims to investigate the relationship of remnant cholesterol with blood pressure control in the general US population. Methods: A total of 3915 participants with self-reported hypertension from NHANES from 2007 to 2018 were included in this study. Demographic and behavior parameters, blood pressure, and blood samples were conducted. Remnant cholesterol was estimated as total cholesterol minus low-density lipoprotein cholesterol minus high-density lipoprotein cholesterol. Control of hypertension was defined as systolic blood pressure less than 140 mmHg and diastolic blood pressure less than 90 mmHg in participants with hypertension. Results: The mean age was 56.98 ± 0.28 years, and 2021 (weighted percentage 51.34%) were female. Among all participants, 2650 participants had their blood pressure well controlled. In multivariate logistic regression, the associations between remnant cholesterol and blood pressure control were statistically significant after adjusting age, sex, race/ethnicity, education level, poverty income ratio, smoking and drinking status, metabolic equivalent, HbA1c, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol (Model 1: OR=0.74, 95% CI: 0.57-0.95; Model 2: OR=0.72, 95% CI: 0.55-0.94; Model 3: OR=0.73, 95% CI: 0.56-0.93; Model 4: OR=0.60, 95% CI: 0.46-0.78). The subgroup analysis revealed generally consistent associations with the main results. Conclusion: Remnant cholesterol is associated with blood pressure control. Targeting remnant cholesterol through lifestyle modifications or lipid-lowering therapies may improve blood pressure control in high-risk patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.